Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    rex_pacis
    wrote on sidst redigeret af
    #144

    I understand your point. If I was 56 and had more than a billion DKK, I would not work anymore. Bye bye JvW 🙂

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #145

      Don´t worry - this is Denmark

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #146

        fully agree GlobalMacro. Also, if something would go wrong with Genmab, he would lose his job AND his fortune, so i agree it is wise to sell a part

        1 Reply Last reply
        0
        • R Offline
          R Offline
          rex_pacis
          wrote on sidst redigeret af
          #147

          I bet he had
          quite a few millions invested in something else already

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #148

            and agree with rex pacis lol, mind you , if he resigns today, he will not get all the warrants that are still not vested...

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #149

              by the way Rachel is very late with her email and Nasdaq publication... the stock is till trading in the US, price-sensitive information should really be coordinated...

              1 Reply Last reply
              0
              • M Offline
                M Offline
                Mscotland
                wrote on sidst redigeret af
                #150

                Amgen - er kommet med nyt fra deres fase 3 studie i forhold til knoglemarvskræft i følge medwatch i dag. Er der nogle af jer kloge mennesker, der har nogle bemærkninger til det?

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #151

                  She wont mail any longer as they informed us on their webside that will not

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #152

                    its not neccessary any longer

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #153

                      Ok, thanks Solsen, I didnt realise that. I am a bit surprised, thought that would need Nasdaq disclosure. Another task for us then here 🙂

                      1 Reply Last reply
                      0
                      • BulderB Offline
                        BulderB Offline
                        Bulder
                        wrote on sidst redigeret af
                        #154

                        @ Mscotland. Kyprolis (carfilzomib) er en protesomhæmmer ligesom Velcade (bortezomib). Disse to var sat op imod hinanden i et fase 3 studie, som faldt ud til Kyprolis' fordel http://wwwext.amgen.com/media/news-releases/2017/02/phase-3-headtohead-trial-showed-kyprolis-carfilzomib-significantly-improved-overall-survival-compared-to-velcade-bortezomib-in-relapsed-or-refractory-multiple-myeloma-patients/ . Heldigvis for det, for det betyder at kombinationen med dara og en proteasomhæmmer blot bliver

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #155

                          endnu bedre med Kyprolis end med Velcade, som i forvejen har vist fantastiske resultater (Castor).

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #156

                            Ja. Novod var ude for nogle dage siden med en analyse af MM markedet. Kyprolis, Velcade, Empliciti etc taber stort til Darzalez og Revlimid i et stærkt voksende marked.

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #157

                              Ja, men de rev-resistente kan så få dara-kyp i stedet.

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mscotland
                                wrote on sidst redigeret af
                                #158

                                Tusind tak Bulder for et MEGET fint svar. Spændende med de kombinationsmuligheder

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #159

                                  Tak Bulder og Solsen.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    peter12
                                    wrote on sidst redigeret af
                                    #160

                                    Har den været vist før ? http://www.ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/limo-chen-phd-on-lung-cancer-and-cd38-resistance-to-immunotherapy/

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #161

                                      Super. Mon der er en engelsk version 🙂

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        mobbyduck1
                                        wrote on sidst redigeret af
                                        #162

                                        haha

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #163

                                          Men der er sekvenser der lyder super godt.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger